Skip to main content
. 2017 Dec 29;9(7):7453–7463. doi: 10.18632/oncotarget.23761

Table 4. Uc.189 expression and clinicopathologic features in patients with endometrial adenocarcinoma.

Characteristics Uc.189 Low/unchanged expression (n = 25) Uc.189 High expression (n = 73) χ2 P-value
Age (years) 0.710 0.400
<60 3 (21.5) 30 (24.2)
≥60 8 (78.5) 44 (75.8)
Local invasion 1.612 0.204
T1+T2 16 (38.1) 36 (19.6)
T3+T4 9 (61.9) 37 (80.4)
Tumor grade 36.993 <0.001
I + II 19 (72.4) 9 (5.7)
III 6 (27.6) 64 (94.3)
TNM stage 39.674 <0.001
I + II 18 (43.2) 19 (14.8)
III + IV 7 (56.8) 54 (85.2)
Nodal status 0.762 0.383
positive 14 (38.9) 48 (16.7)
negative 11 (61.1) 25 (83.3)
Distant metastasis 40.462 <0.001
M0 24 (46.3) 17(9.1)
M1 1 (53.7) 56 (90.9)
Tumor size (cm) 29.518 <0.001
≥5 7 (64.3) 60 (10.0)
<5 18 (35.7) 10 (90.0)
Depth of tumor invasion 1.612 0.204
Mucosa, submucosa 16 (38.1) 36 (19.6)
muscularis propria, serosa, adjacent structures 9 (61.9) 37 (80.4)